相关实验视频
Updated: Jun 27, 2026

10:45
Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
Published on: May 25, 2017
14.3K
更新的MELD与酒精相关肝炎的预后之间的关系:为更高效的试验设计提供了机会
Mustafa Al-Karaghouli1, Meritxell Ventura-Cots2,3, Yu Jun Wong1
1Division of Gastroenterology (Liver Unit). University of Alberta, Edmonton, Alberta, Canada.
Hepatology communications
|July 31, 2024
概括
更新的末期肝病模型 (MELD) 评分准确预测酒精相关性肝炎 (AH) 的死亡率. 之前的MELD得分除了最新得分之外没有增加预后价值,为临床决策和试验设计提供了信息.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 临床预后 临床预后
- 医学统计 医学统计
背景情况:
- 与酒精相关的肝炎 (AH) 具有显著的死亡风险.
- 末期肝病模型 (MELD) 评分对于预测短期死亡率和指导AH治疗至关重要.
- 在AH中经常更新的MELD得分的预后价值需要进一步调查移植分配和临床试验设计.
研究的目的:
- 调查更新的MELD得分在AH患者前性收集队列中的预测性表现.
- 为了确定是否之前的MELD得分保留预后价值,一旦一个更当前的MELD得分是可用的.
- 评估MELD得分在提高AH干预临床试验效率方面的有用性.
主要方法:
- 利用了从InTeam联盟中前性收集的307名患有酒精相关肝炎的患者队列.
- 分析了859个MELD得分,这些得分是在入院后60天内收集的.
- 采用联合模型方法来评估更新的MELD得分对90天内死亡或移植的时间的预测值.
主要成果:
- 更新的MELD测量表明,死亡或移植的预后值很强 (HR:1.20,p < 0.0001).
- 之前的MELD评分没有提供超出最新MELD评分的额外预测价值.
- 28日的MELD (MELD28) 显示了随后死亡率/移植的显著预测值 (HR:1.18).
结论:
- 在整个AH疾病轨迹中更新的MELD得分有效预测随后的死亡率或移植.
- 将MELD28纳入顺序结果表 (死亡或移植) 可以提高AH随机对照试验的效率.
- 结果支持使用当前的MELD评分进行预后评估,并建议对AH临床试验进行方法改进.
相关概念视频
Hypothesis Test for Test of Independence
The test of independence is a chi-square-based test used to determine whether two variables or factors are independent or dependent. This hypothesis test is used to examine the independence of the variables. One can construct two qualitative survey questions or experiments based on the variables in a contingency table. The goal is to see if the two variables are unrelated (independent) or related (dependent). The null and alternative hypotheses for this test are:
H0: The two variables (factors)...
H0: The two variables (factors)...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...

